In this episode of Critical Matters, we will discuss the role of early neuromuscular blockers in the treatment of severe ARDS.Our guest is Dr. Arthur Slutsky, Professor of Medicine, Surgery and Biomedical Engineering at the University of Toronto. Dr. Slutsky is a world-renowned clinician and investigator with a special interest in ARDS. We will review a recently published clinical trial and discuss its result within the context of available evidence.Additional Resources:Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome: https://bit.ly/2YwXxnGNeuromuscular Blocking Agents in ARDS: https://bit.ly/2KmMZiAEarly Neuromuscular Blockade in the Acute Respiratory Distress Syndrome: https://bit.ly/2ROMJeaEarly Paralytic Agents for ARDS? Yes, No, and Sometimes: https://bit.ly/2ZONDuBBooks Mentioned in this Episode:Nudge: Improving Decisions About Health, Wealth and Happiness by Richard H. Thaler and Cass R. Sunstein: https://amzn.to/2Kv75pDMisbehaving: The Making of Behavioral Economics by Richard H. Thaler: https://amzn.to/2YRm5DcBad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou: https://amzn.to/2MPDjyN